Doctors warn that early signs of ovarian cancer are often mistaken for regular weight gain, leading to many cases being discovered only at advanced stages. Research from Mayo Clinic highlights why these early warnings can be easy to miss.
About three in four ovarian cancer cases are diagnosed when the disease has already spread beyond the ovaries to the abdomen, lymph nodes, or distant organs. The most common early symptom is bloating, but many people interpret it as normal weight changes.
Why Bloating Gets Overlooked
Ovarian tumors can cause ascites, the buildup of fluid in the abdomen. This makes the belly swell and firm up, resembling ordinary weight gain. Midlife weight changes and gradual increases in body size often make this symptom harder to recognize as serious.
Dr. Nagarajan Kannan, a researcher at Mayo Clinic, studies how ovarian cancer starts in the fallopian tubes. Gynecologic oncologist Dr. Jamie Bakkum-Gamez explains that the most common and aggressive form of the disease often begins there. Feeling full after only a few bites — called early satiety — can also be an early warning sign.
What to Watch For
Common symptoms include persistent bloating, pelvic or back pain, feeling full quickly, and changes in bowel or bladder habits. Frequent urination or urgency can occur when a growing tumor puts pressure on the bladder.
Doctors advise paying attention to patterns rather than isolated symptoms. If new, frequent, or lasting symptoms continue for two weeks or more, they should be discussed with a clinician. Any bleeding after menopause also needs immediate evaluation.
Why Routine Screening Falls Short
Currently, no reliable screening test exists for people without symptoms or high genetic risk. The U.S. Preventive Services Task Force does not recommend routine screening with pelvic ultrasound or the CA-125 blood test, since these methods have not lowered death rates and can lead to unnecessary surgery from false positives.
CA-125 levels can rise for reasons unrelated to cancer, such as infection or menstruation. Imaging can help detect tumors when symptoms are present, but the smallest and earliest tumors often remain invisible. This makes awareness of ongoing symptoms essential.
What Raises Ovarian Cancer Risk
Inherited changes in the BRCA1 and BRCA2 genes increase the chance of developing ovarian cancer. According to the National Cancer Institute, women with harmful BRCA1 mutations face a 39–58% lifetime risk, while those with BRCA2 mutations face a 13–29% risk.
Family history can provide important clues. A pattern of ovarian, breast, or fallopian tube cancers in the family should prompt genetic counseling. Some women reduce risk by removing their fallopian tubes during other gynecologic surgeries, a procedure known as opportunistic salpingectomy. It aims to prevent cancer if cell changes begin in the tubes.
The Role of the Fallopian Tube
A recent Mayo Clinic study examined fallopian tube cells from a young patient with rare TP53 and BRCA2 mutations. The researchers found fewer ciliated cells and signs of chronic inflammation — early changes often seen before invasive cancer develops.
These findings suggest that ovarian cancer may take years to evolve from early cell changes. Mapping these stages could one day allow doctors to detect the disease at a precancerous stage. Researchers are also studying “p53 signatures,” clusters of cells showing early signs of genetic instability linked to cancer.
Understanding how ovarian cancer starts in the fallopian tube supports preventive approaches, including removing the tubes in women who are finished having children.
A Plan for Paying Attention
Doctors stress the importance of knowing your body’s normal patterns. Persistent bloating, fullness, or urinary changes should not be ignored. Keeping a record of symptoms helps clinicians decide whether further evaluation is needed.
Patients should share their full family history, including cancers on both parents’ sides. Testing like pelvic exams or ultrasounds should respond to clear changes rather than serve as general screening.
For women planning pelvic surgery in the future, prevention strategies can be discussed in advance. Decisions should consider age, fertility goals, and personal or family cancer risk.
Related topics
Early First Trimester Scans Improve Detection of Major Fetal Anomalies
Cervical Cancer Survival Improve with Consistent HIV Treatment, Study Reveals
Chiron Doubles Support With Expanded Campaign Offering Free Breast Screening
